Clinical trial
Study to Investigate the Immune Response and Safety of Prophylactic Vaccines in Patients Treated for Multiple Sclerosis
NCT02275741 is registered in ClinicalTrials.gov with Dr. med. Micha Loebermann as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study to Investigate the Immune Response and Safety of Prophylactic Vaccines in Patients Treated for Multiple Sclerosis
- Lead sponsor
- Dr. med. Micha Loebermann
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2009
- Completion date
- November 30, 2016
- Enrollment
- 226 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.